{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:10:34Z","timestamp":1790478634766,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570374"],"award-info":[{"award-number":["81570374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Arterial tone is regulated by multiple ligand-receptor interactions, and its dysregulation is involved in ischemic conditions such as acute coronary spasm or syndrome. Understanding the distribution of vasoactive receptors on different arteries may help guide the development of tissue-specific vasoactive treatments against arterial dysfunction. Tissues were harvested from coronary, mesenteric, pulmonary, renal and peripheral human artery (n\u2009=\u20096 samples of each) and examined using a human antibody array to determine the expression of 29 vasoactive receptors and 3 endothelin ligands. Across all types of arteries, outer diameter ranged from 2.24\u2009\u00b1\u20090.63 to 3.65\u2009\u00b1\u20090.40\u00a0mm, and AVPR1A was the most abundant receptor. The expression level of AVPR1A in pulmonary artery was similar to that in renal artery, 2.2 times that in mesenteric artery, 1.9 times that in peripheral artery, and 2.2 times that in coronary artery. Endothelin-1 was expressed at significantly higher levels in pulmonary artery than peripheral artery (8.8 times), mesenteric artery (5.3 times), renal artery (7.9 times), and coronary artery (2.4 times). Expression of ADRA2B was significantly higher in coronary artery than peripheral artery. Immunohistochemistry revealed abundant ADRA2B in coronary artery, especially vessels with diameters below 50\u00a0\u03bcm, but not in myocardium. ADRA2C, in contrast, was expressed in both myocardium and blood vessels. The high expression of ADRA2B in coronary artery but not myocardium highlights the need to further characterize its function. Our results help establish the distribution and relative levels of tone-related receptors in different types of arteries, which may guide artery-specific treatments.<\/jats:p>","DOI":"10.1038\/s41598-020-72352-5","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T10:03:11Z","timestamp":1600682591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Distribution and relative expression of vasoactive receptors on arteries"],"prefix":"10.1038","volume":"10","author":[{"given":"Xinhao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"issue":"252","key":"72352_CR1","doi-asserted-by":"publisher","first-page":"252ps9","DOI":"10.1126\/scitranslmed.3008910","volume":"6","author":"A Eichmann","year":"2014","unstructured":"Eichmann, A. & Brunet, I. Arterial innervation in development and disease. Sci Transl Med. 6(252), 252ps9. https:\/\/doi.org\/10.1126\/scitranslmed.3008910 (2014).","journal-title":"Sci Transl Med."},{"key":"72352_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12370","author":"DG Welsh","year":"2017","unstructured":"Welsh, D. G. & Longden, T. A. Endothelial signaling and the dynamic regulation of arterial tone: A surreptitious relationship. Microcirculation. https:\/\/doi.org\/10.1111\/micc.12370 (2017).","journal-title":"Microcirculation."},{"issue":"23 SUPPL.","key":"72352_CR3","doi-asserted-by":"publisher","first-page":"III27","DOI":"10.1161\/01.cir.0000131515.03336.f8","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon, J. & Ganz, P. Role of endothelial dysfunction in atherosclerosis. Circulation 109(23 SUPPL.), III27\u2013III32. https:\/\/doi.org\/10.1161\/01.cir.0000131515.03336.f8 (2004).","journal-title":"Circulation"},{"issue":"3","key":"72352_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1161\/CIRCINTERVENTIONS.114.001558","volume":"7","author":"GA Lanza","year":"2014","unstructured":"Lanza, G. A. & Crea, F. Acute coronary syndromes without obstructive coronary atherosclerosis: The tiles of a complex puzzle. Circ. Cardiovasc. Interv. 7(3), 278\u2013281. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.114.001558 (2014).","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"3","key":"72352_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/SHK.0000000000000777","volume":"47","author":"TD Corr\u00eaa","year":"2017","unstructured":"Corr\u00eaa, T. D., Filho, R. R., Assun\u00e7\u00e3o, M. S. C., Silva, E. & Lima, A. Vasodilators in septic shock resuscitation: A clinical perspective. Shock. 47(3), 269\u2013275. https:\/\/doi.org\/10.1097\/SHK.0000000000000777 (2017).","journal-title":"Shock."},{"issue":"12","key":"72352_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1111\/eci.12553","volume":"45","author":"G Grassi","year":"2015","unstructured":"Grassi, G., Seravalle, G. & Mancia, G. Sympathetic activation in cardiovascular disease: Evidence, clinical impact and therapeutic implications. Eur. J. Clin. Invest. 45(12), 1367\u20131375. https:\/\/doi.org\/10.1111\/eci.12553 (2015).","journal-title":"Eur. J. Clin. Invest."},{"issue":"5276","key":"72352_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1126\/science.273.5276.803","volume":"273","author":"RE Link","year":"1996","unstructured":"Link, R. E. et al. Cardiovascular regulation in mice lacking \u03b12-adrenergic receptor subtypes b and c. Science (80-) 273(5276), 803\u2013805. https:\/\/doi.org\/10.1126\/science.273.5276.803 (1996).","journal-title":"Science (80-)"},{"issue":"8","key":"72352_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41569-019-0176-3","volume":"16","author":"N Dhaun","year":"2019","unstructured":"Dhaun, N. & Webb, D. J. Endothelins in cardiovascular biology and therapeutics. Nat. Rev. Cardiol. 16(8), 491\u2013502. https:\/\/doi.org\/10.1038\/s41569-019-0176-3 (2019).","journal-title":"Nat. Rev. Cardiol."},{"issue":"14","key":"72352_CR9","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1056\/NEJMra040291","volume":"351","author":"M Humbert","year":"2004","unstructured":"Humbert, M., Sitbon, O. & Simonneau, G. Treatment of pulmonary arterial hypertension. N. Engl. J. Med. 351(14), 1426\u20131436. https:\/\/doi.org\/10.1056\/NEJMra040291 (2004).","journal-title":"N. Engl. J. Med."},{"issue":"9699","key":"72352_CR10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0140-6736(09)61500-2","volume":"374","author":"MA Weber","year":"2009","unstructured":"Weber, M. A. et al. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet 374(9699), 1423\u20131431. https:\/\/doi.org\/10.1016\/S0140-6736(09)61500-2 (2009).","journal-title":"Lancet"},{"issue":"5","key":"72352_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1161\/HYPERTENSIONAHA.110.156976","volume":"56","author":"GL Bakris","year":"2010","unstructured":"Bakris, G. L. et al. Divergent results using clinic and ambulatory blood pressures: Report of a darusentan-resistant hypertension trial. Hypertension 56(5), 824\u2013830. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.156976 (2010).","journal-title":"Hypertension"},{"issue":"9","key":"72352_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/TP.0b013e31825f0fbe","volume":"94","author":"A Raina","year":"2012","unstructured":"Raina, A., Horn, E. T. & Benza, R. L. The pathophysiology of endothelin in complications after solid organ transplantation: A potential novel therapeutic role for endothelin receptor antagonists. Transplantation 94(9), 885\u2013893. https:\/\/doi.org\/10.1097\/TP.0b013e31825f0fbe (2012).","journal-title":"Transplantation"},{"issue":"1","key":"72352_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/10739680590895028","volume":"12","author":"SS Segal","year":"2005","unstructured":"Segal, S. S. Regulation of blood flow in the microcirculation. Microcirculation. 12(1), 33\u201345. https:\/\/doi.org\/10.1080\/10739680590895028 (2005).","journal-title":"Microcirculation."},{"issue":"6","key":"72352_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1042\/CS20040068","volume":"106","author":"A Malliani","year":"2004","unstructured":"Malliani, A. & Montano, N. Sympathetic overactivity in ischaemic heart disease. Clin Sci. 106(6), 567\u2013568. https:\/\/doi.org\/10.1042\/CS20040068 (2004).","journal-title":"Clin Sci."},{"issue":"14","key":"72352_CR15","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.113.004046","volume":"129","author":"AE Moran","year":"2014","unstructured":"Moran, A. E. et al. The global burden of ischemic heart disease in 1990 and 2010: The global burden of disease 2010 study. Circulation 129(14), 1493\u20131501. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.004046 (2014).","journal-title":"Circulation"},{"key":"72352_CR16","first-page":"F62","volume":"19 Suppl F","author":"WJ Remme","year":"1998","unstructured":"Remme, W. J. The sympathetic nervous system and ischaemic heart disease. Eur. Heart J. 19 Suppl F, F62-71 (1998).","journal-title":"Eur. Heart J."},{"issue":"1","key":"72352_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/CIRCULATIONAHA.106.678995","volume":"116","author":"MA Samuels","year":"2007","unstructured":"Samuels, M. A. The brain-heart connection. Circulation 116(1), 77\u201384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.678995 (2007).","journal-title":"Circulation"},{"issue":"1","key":"72352_CR18","doi-asserted-by":"publisher","first-page":"H433","DOI":"10.1152\/ajpheart.01262.2006","volume":"293","author":"DL Jardine","year":"2007","unstructured":"Jardine, D. L., Charles, C. J., Frampton, C. M. & Richards, A. M. Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in a conscious sheep model. Am. J. Physiol Heart Circ. Physiol. 293(1), H433\u2013H439. https:\/\/doi.org\/10.1152\/ajpheart.01262.2006 (2007).","journal-title":"Am. J. Physiol Heart Circ. Physiol."},{"issue":"7","key":"72352_CR19","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1161\/01.RES.86.7.816","volume":"86","author":"JM Cao","year":"2000","unstructured":"Cao, J. M. et al. Nerve sprouting and sudden cardiac death. Circ. Res. 86(7), 816\u2013821. https:\/\/doi.org\/10.1161\/01.RES.86.7.816 (2000).","journal-title":"Circ. Res."},{"issue":"4","key":"72352_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jacc.2009.08.057","volume":"55","author":"SW Sharkey","year":"2010","unstructured":"Sharkey, S. W. et al. Natural history and expansive clinical profile of stress (Tako-Tsubo) cardiomyopathy. J. Am. Coll. Cardiol. 55(4), 333\u2013341. https:\/\/doi.org\/10.1016\/j.jacc.2009.08.057 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"17","key":"72352_CR21","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1161\/01.CIR.0000163551.33812.1A","volume":"111","author":"E Nyg\u00e5rd","year":"2005","unstructured":"Nyg\u00e5rd, E. et al. Effects of high thoracic epidural analgesia on myocardial blood flow in patients with ischemic heart disease. Circulation 111(17), 2165\u20132170. https:\/\/doi.org\/10.1161\/01.CIR.0000163551.33812.1A (2005).","journal-title":"Circulation"},{"issue":"4","key":"72352_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S1053-0770(03)00182-4","volume":"17","author":"N Svorkdal","year":"2003","unstructured":"Svorkdal, N. Pro: Anesthesiologists\u2019 role in treating refractory angina: Spinal cord stimulators, thoracic epidurals, therapeutic angiogenesis, and other emerging options. J. Cardiothorac. Vasc. Anesth. 17(4), 536\u2013545. https:\/\/doi.org\/10.1016\/S1053-0770(03)00182-4 (2003).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"16","key":"72352_CR23","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1161\/01.CIR.99.16.2090","volume":"99","author":"D Baumgart","year":"1999","unstructured":"Baumgart, D. et al. Augmented \u03b1-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 99(16), 2090\u20132097. https:\/\/doi.org\/10.1161\/01.CIR.99.16.2090 (1999).","journal-title":"Circulation"},{"issue":"4","key":"72352_CR24","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/01.CIR.86.4.1116","volume":"86","author":"C Indolfi","year":"1992","unstructured":"Indolfi, C. et al. Role of \u03b12-adrenoceptors in normal and atherosclerotic human coronary circulation. Circulation 86(4), 1116\u20131124. https:\/\/doi.org\/10.1161\/01.CIR.86.4.1116 (1992).","journal-title":"Circulation"},{"issue":"5","key":"72352_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1042\/CS20020299","volume":"104","author":"A Snapir","year":"2003","unstructured":"Snapir, A. et al. Effects of common polymorphisms in the \u03b11A-, \u03b12B-, \u03b21- and \u03b22-adrenoreceptors on haemodynamic responses to adrenaline. Clin. Sci. 104(5), 509\u2013520. https:\/\/doi.org\/10.1042\/CS20020299 (2003).","journal-title":"Clin. Sci."},{"issue":"6","key":"72352_CR26","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/S0735-1097(01)01201-3","volume":"37","author":"PB Adamson","year":"2001","unstructured":"Adamson, P. B. & Vanoli, E. An insertion\/deletion polymorphism in the \u03b12B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J. Am. Coll. Cardiol. 37(6), 1516\u20131522. https:\/\/doi.org\/10.1016\/S0735-1097(01)01201-3 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"72352_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0735-1097(02)02702-X","volume":"41","author":"A Snapir","year":"2003","unstructured":"Snapir, A. et al. Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J. Am. Coll. Cardiol. 41(2), 190\u2013194. https:\/\/doi.org\/10.1016\/S0735-1097(02)02702-X (2003).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"72352_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ahj.2009.07.023","volume":"158","author":"JA Laukkanen","year":"2009","unstructured":"Laukkanen, J. A., M\u00e4kikallio, T. H., Kauhanen, J. & Kurl, S. Insertion\/deletion polymorphism in \u03b12-adrenergic receptor gene is a genetic risk factor for sudden cardiac death. Am. Heart J. 158(4), 615\u2013621. https:\/\/doi.org\/10.1016\/j.ahj.2009.07.023 (2009).","journal-title":"Am. Heart J."},{"issue":"5","key":"72352_CR29","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","volume":"95","author":"DW Landry","year":"1997","unstructured":"Landry, D. W. et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95(5), 1122\u20131125. https:\/\/doi.org\/10.1161\/01.CIR.95.5.1122 (1997).","journal-title":"Circulation"},{"issue":"7","key":"72352_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/BF01694349","volume":"18","author":"MA Hayes","year":"1992","unstructured":"Hayes, M. A., Yau, E. H. S., Hinds, C. J. & Watson, J. D. Symmetrical peripheral gangrene: association with noradrenaline administration. Intensive Care Med. 18(7), 433\u2013436. https:\/\/doi.org\/10.1007\/BF01694349 (1992).","journal-title":"Intensive Care Med."},{"issue":"6","key":"72352_CR31","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1378\/chest.124.6.2256","volume":"124","author":"FMP Van Haren","year":"2003","unstructured":"Van Haren, F. M. P., Rozendaal, F. W. & Van Der Hoeven, J. G. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 124(6), 2256\u20132260. https:\/\/doi.org\/10.1378\/chest.124.6.2256 (2003).","journal-title":"Chest"},{"issue":"11","key":"72352_CR32","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1097\/01.CCM.0000094260.05266.F4","volume":"31","author":"S Klinzing","year":"2003","unstructured":"Klinzing, S., Simon, M., Reinhart, K., Bredle, D. L. & Meier-Hellmann, A. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med. 31(11), 2646\u20132650. https:\/\/doi.org\/10.1097\/01.CCM.0000094260.05266.F4 (2003).","journal-title":"Crit Care Med."},{"issue":"5","key":"72352_CR33","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/01.CCM.0000059722.94182.79","volume":"31","author":"MW D\u00fcnser","year":"2003","unstructured":"D\u00fcnser, M. W. et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors. Crit Care Med. 31(5), 1394\u20131398. https:\/\/doi.org\/10.1097\/01.CCM.0000059722.94182.79 (2003).","journal-title":"Crit Care Med."},{"issue":"9","key":"72352_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell, J. A. et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N. Engl. J. Med. 358(9), 877\u2013887. https:\/\/doi.org\/10.1056\/NEJMoa067373 (2008).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"72352_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00000542-200501000-00016","volume":"102","author":"A Ouattara","year":"2005","unstructured":"Ouattara, A. et al. Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart. Anesthesiology 102(1), 85\u201392. https:\/\/doi.org\/10.1097\/00000542-200501000-00016 (2005).","journal-title":"Anesthesiology"},{"issue":"3","key":"72352_CR36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1161\/01.RES.66.3.710","volume":"66","author":"WA Boyle","year":"1990","unstructured":"Boyle, W. A. & Segel, L. D. Attenuation of vasopressin-mediated coronary constriction and myocardial depression in the hypoxic heart. Circ. Res. 66(3), 710\u2013721. https:\/\/doi.org\/10.1161\/01.RES.66.3.710 (1990).","journal-title":"Circ. Res."},{"issue":"6","key":"72352_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/SHK.0b013e31828aac4b","volume":"39","author":"OB Boucheix","year":"2013","unstructured":"Boucheix, O. B., Milano, S. P., Henriksson, M. & Reinheimer, T. M. Selepressin, a new V1A receptor agonist: hemodynamic comparison to vasopressin in dogs. Shock. 39(6), 533\u2013538. https:\/\/doi.org\/10.1097\/SHK.0b013e31828aac4b (2013).","journal-title":"Shock."},{"issue":"3","key":"72352_CR38","doi-asserted-by":"publisher","first-page":"R98","DOI":"10.1186\/cc7930","volume":"13","author":"T Indrambarya","year":"2009","unstructured":"Indrambarya, T., Boyd, J. H., Wang, Y., McConechy, M. & Walley, K. R. Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice. Crit Care. 13(3), R98. https:\/\/doi.org\/10.1186\/cc7930 (2009).","journal-title":"Crit Care."},{"issue":"8","key":"72352_CR39","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s001340101014","volume":"27","author":"CL Holmes","year":"2001","unstructured":"Holmes, C. L., Walley, K. R., Chittock, D. R., Lehman, T. & Russell, J. A. The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med. 27(8), 1416\u20131421. https:\/\/doi.org\/10.1007\/s001340101014 (2001).","journal-title":"Intensive Care Med."},{"issue":"1","key":"72352_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","volume":"36","author":"AC Gordon","year":"2010","unstructured":"Gordon, A. C. et al. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med. 36(1), 83\u201391. https:\/\/doi.org\/10.1007\/s00134-009-1687-x (2010).","journal-title":"Intensive Care Med."},{"issue":"3","key":"72352_CR41","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1378\/chest.12-1106","volume":"143","author":"SM Brown","year":"2013","unstructured":"Brown, S. M. et al. Survival after shock requiring high-dose vasopressor therapy. Chest 143(3), 664\u2013671. https:\/\/doi.org\/10.1378\/chest.12-1106 (2013).","journal-title":"Chest"},{"issue":"4","key":"72352_CR42","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/01.CIR.81.4.1415","volume":"81","author":"H Vierhapper","year":"1990","unstructured":"Vierhapper, H., Wagner, O., Nowotny, P. & Waldh\u00e4usl, W. Effect of endothelin-1 in man. Circulation 81(4), 1415\u20131418. https:\/\/doi.org\/10.1161\/01.CIR.81.4.1415 (1990).","journal-title":"Circulation"},{"issue":"6","key":"72352_CR43","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","volume":"114","author":"DJ Stewart","year":"1991","unstructured":"Stewart, D. J., Levy, R. D., Cernacek, P. & Langleben, D. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?. Ann. Intern Med. 114(6), 464\u2013469. https:\/\/doi.org\/10.7326\/0003-4819-114-6-464 (1991).","journal-title":"Ann. Intern Med."},{"issue":"11","key":"72352_CR44","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1517\/14796678.1.3.299","volume":"61","author":"H Cohen","year":"2004","unstructured":"Cohen, H., Chahine, C., Hui, A. & Mukherji, R. Bosentan therapy for pulmonary arterial hypertension. Am. J. Health Pharm. 61(11), 1107\u20131119. https:\/\/doi.org\/10.1517\/14796678.1.3.299 (2004).","journal-title":"Am. J. Health Pharm."},{"issue":"9288","key":"72352_CR45","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","volume":"358","author":"RN Channick","year":"2001","unstructured":"Channick, R. N. et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study. Lancet 358(9288), 1119\u20131123. https:\/\/doi.org\/10.1016\/S0140-6736(01)06250-X (2001).","journal-title":"Lancet"},{"issue":"9","key":"72352_CR46","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1213917","volume":"369","author":"T Pulido","year":"2013","unstructured":"Pulido, T. et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N. Engl. J. Med. 369(9), 809\u2013818. https:\/\/doi.org\/10.1056\/NEJMoa1213917 (2013).","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"72352_CR47","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","volume":"117","author":"N Gali\u00e8","year":"2008","unstructured":"Gali\u00e8, N. et al. Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-Blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation 117(23), 3010\u20133019. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.742510 (2008).","journal-title":"Circulation"},{"issue":"2\u20133","key":"72352_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0014-2999(03)01424-9","volume":"464","author":"WH Chau","year":"2003","unstructured":"Chau, W. H. et al. Role of Na+\/H+ exchanger in acetylcholine-mediated pulmonary artery contraction of Spontaneously hypertensive rats. Eur. J. Pharmacol. 464(2\u20133), 177\u2013187. https:\/\/doi.org\/10.1016\/S0014-2999(03)01424-9 (2003).","journal-title":"Eur. J. Pharmacol."},{"key":"72352_CR49","unstructured":"Global strategy for asthma management and prevention. https:\/\/ginasthma.org\/wp-content\/uploads\/2020\/04\/GINA-2020-full-report_-final-_wms.pdf (2020)."},{"key":"72352_CR50","doi-asserted-by":"publisher","unstructured":"Singh, D. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur. Respir. J. 53(5). https:\/\/doi.org\/10.1183\/13993003.00164-2019 (2019).","DOI":"10.1183\/13993003.00164-2019"},{"issue":"9","key":"72352_CR51","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1161\/CIRCULATIONAHA.117.027451","volume":"137","author":"D Da Silva Gon\u00e7alves B\u00f3s","year":"2018","unstructured":"Da Silva Gon\u00e7alves B\u00f3s, D. et al. Contribution of impaired parasympathetic activity to right ventricular dysfunction and pulmonary vascular remodeling in pulmonary arterial hypertension. Circulation 137(9), 910\u2013924. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.027451 (2018).","journal-title":"Circulation"},{"issue":"3","key":"72352_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00395-017-0611-8","volume":"112","author":"C Jiang","year":"2017","unstructured":"Jiang, C. et al. Vasopressors induce passive pulmonary hypertension by blood redistribution from systemic to pulmonary circulation. Basic Res. Cardiol. 112(3), 21. https:\/\/doi.org\/10.1007\/s00395-017-0611-8 (2017).","journal-title":"Basic Res. Cardiol."},{"issue":"11","key":"72352_CR53","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/s0895-7061(01)02074-x","volume":"14","author":"E Schiffrin","year":"2001","unstructured":"Schiffrin, E. Role of endothelin-1 in hypertension and vascular disease. Am. J. Hypertens. 14(11), S83\u2013S89. https:\/\/doi.org\/10.1016\/s0895-7061(01)02074-x (2001).","journal-title":"Am. J. Hypertens."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72352-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:37:24Z","timestamp":1670355444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72352-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72352"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72352-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15383"}}